DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Atacand (Candesartan Cilexetil) - Adverse Event Reports - Serious Event - Dermatitis Psoriasiform

 



Index of reports > Cases resulting in a serious event (125) > Cases with Dermatitis Psoriasiform (6)

Below is the selection of adverse event reports related to Atacand (Candesartan Cilexetil) that includes cases resulting in a serious event where reactions include dermatitis psoriasiform.

Adverse event in 73 year old female receiving Atacand (Candesartan Cilexetil)

Reported by a individual with unspecified qualification from France on 2007-04-27

Patient: 73 year old female, weighing 78.0 kg (171.6 pounds)

Adverse reactions / side effects: Cytomegalovirus Antibody Positive, Skin Exfoliation, Parvovirus B19 Serology Positive, Eczema, Dermatitis Psoriasiform, Pruritus Generalised, C-Reactive Protein Increased, Prurigo, Antinuclear Antibody Positive, Epstein-Barr Virus Antigen Positive, Arthralgia, Serology Abnormal, Scar, RED Blood Cell Sedimentation Rate Increased, Toxic Skin Eruption, Inflammation

Adverse event resulted in: hospitalization

Suspect drug(s):
Tareg
    Dosage: 160 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2004-10-15
    End date: 2006-10-03

Atacand
    Dosage: 16 mg/day
    Administration route: Oral
    Start date: 2006-10-04
    End date: 2006-12-29

Micardis
    Dosage: 1 df, qd
    Administration route: Oral
    Start date: 2006-12-30
    End date: 2007-01-15



Adverse event in 73 year old female receiving Atacand (Candesartan Cilexetil)

Reported by a physician on 2007-04-24

Patient: 73 year old female, weighing 78.0 kg (171.6 pounds)

Adverse reactions / side effects: Dermatitis Psoriasiform

Adverse event resulted in: hospitalization

Suspect drug(s):
Micardis
    Administration route: Oral
    Start date: 2006-12-30
    End date: 2007-01-15

Tareg
    Administration route: Oral
    Start date: 2004-10-15
    End date: 2006-10-03

Atacand
    Administration route: Oral
    Start date: 2006-10-04
    End date: 2006-12-29



Adverse event in 73 year old female receiving Atacand (Candesartan Cilexetil)

Reported by a health professional (non-physician/pharmacist) from France on 2007-04-17

Patient: 73 year old female, weighing 78.0 kg (171.6 pounds)

Adverse reactions / side effects: Dermatitis Psoriasiform

Adverse event resulted in: hospitalization

Suspect drug(s):
Atacand
    Administration route: Oral
    Start date: 2006-10-04
    End date: 2006-12-29

Tareg
    Administration route: Oral
    Start date: 2004-10-15
    End date: 2006-10-03

Micardis
    Administration route: Oral
    Start date: 2006-12-30
    End date: 2007-01-15



Adverse event in 73 year old female receiving Atacand (Candesartan Cilexetil)

Reported by a individual with unspecified qualification from France on 2007-03-27

Patient: 73 year old female, weighing 78.0 kg (171.6 pounds)

Adverse reactions / side effects: Cytomegalovirus Antibody Positive, Skin Exfoliation, Parvovirus B19 Serology Positive, Eczema, Dermatitis Psoriasiform, Pruritus Generalised, Antinuclear Antibody Positive, Arthralgia, C-Reactive Protein Increased, Epstein-Barr Virus Antigen Positive, Serology Abnormal, Toxic Skin Eruption, Prurigo, RED Blood Cell Sedimentation Rate Increased, Inflammation

Adverse event resulted in: hospitalization

Suspect drug(s):
Tareg
    Dosage: 160 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2004-10-15
    End date: 2006-10-03

Atacand
    Dosage: 16 mg/day
    Administration route: Oral
    Start date: 2006-10-04
    End date: 2006-12-29

Micardis
    Dosage: 1 df, qd
    Administration route: Oral
    Start date: 2006-12-30
    End date: 2007-01-15



Adverse event in 73 year old female receiving Atacand (Candesartan Cilexetil)

Reported by a health professional (non-physician/pharmacist) from France on 2007-03-22

Patient: 73 year old female, weighing 78.0 kg (171.6 pounds)

Adverse reactions / side effects: Dermatitis Psoriasiform

Adverse event resulted in: hospitalization

Suspect drug(s):
Atacand
    Administration route: Oral
    Start date: 2006-10-04
    End date: 2006-12-29

Tareg
    Administration route: Oral
    Start date: 2004-10-15
    End date: 2006-10-03

Micardis
    Administration route: Oral
    Start date: 2006-12-30
    End date: 2007-01-15



Adverse event in 73 year old female receiving Atacand (Candesartan Cilexetil)

Reported by a physician on 2007-03-19

Patient: 73 year old female, weighing 78.0 kg (171.6 pounds)

Adverse reactions / side effects: Dermatitis Psoriasiform

Adverse event resulted in: hospitalization

Suspect drug(s):
Micardis
    Administration route: Oral
    Start date: 2006-12-30
    End date: 2007-01-15

Tareg
    Administration route: Oral
    Start date: 2004-10-15
    End date: 2006-10-03

Atacand
    Administration route: Oral
    Start date: 2006-10-04
    End date: 2006-12-29

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009